Public Employees Retirement System of Ohio Has $296,000 Position in Patheon NV (PTHN)
Public Employees Retirement System of Ohio continued to hold its stake in Patheon NV (NASDAQ:PTHN) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,236 shares of the company’s stock at the end of the first quarter. Public Employees Retirement System of Ohio’s holdings in Patheon NV were worth $296,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the stock. Zweig DiMenna Associates LLC bought a new stake in Patheon NV during the first quarter worth about $6,585,000. Ameriprise Financial Inc. raised its position in shares of Patheon NV by 47.6% in the first quarter. Ameriprise Financial Inc. now owns 1,803,720 shares of the company’s stock worth $47,511,000 after buying an additional 581,914 shares during the period. Three Peaks Capital Management LLC acquired a new position in shares of Patheon NV during the first quarter worth approximately $2,641,000. UBS Asset Management Americas Inc. acquired a new position in shares of Patheon NV during the first quarter worth approximately $302,000. Finally, Forward Management LLC raised its position in shares of Patheon NV by 67.4% in the first quarter. Forward Management LLC now owns 8,714 shares of the company’s stock worth $230,000 after buying an additional 3,509 shares during the period.
Shares of Patheon NV (PTHN) traded down 0.09% on Tuesday, hitting $34.92. The stock had a trading volume of 40,877 shares. Patheon NV has a 52 week low of $23.72 and a 52 week high of $35.10. The company has a market cap of $5.07 billion and a price-to-earnings ratio of 44.77. The firm has a 50 day moving average price of $34.87 and a 200-day moving average price of $30.87.
Patheon NV (NASDAQ:PTHN) last posted its quarterly earnings data on Thursday, June 8th. The company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.01. The business had revenue of $483.40 million during the quarter, compared to analyst estimates of $466.08 million. Patheon NV’s quarterly revenue was up 3.2% compared to the same quarter last year. Analysts anticipate that Patheon NV will post $1.14 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This piece was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/08/08/public-employees-retirement-system-of-ohio-has-296000-position-in-patheon-nv-pthn.html.
A number of brokerages have recently commented on PTHN. Piper Jaffray Companies lowered Patheon NV from an “overweight” rating to a “neutral” rating in a report on Monday, May 15th. William Blair lowered Patheon NV from an “outperform” rating to a “market perform” rating in a report on Monday, May 15th. Jefferies Group LLC reissued a “hold” rating and set a $35.00 price target on shares of Patheon NV in a report on Friday, July 21st. Leerink Swann lowered Patheon NV from an “outperform” rating to a “market perform” rating and raised their price target for the company from $31.00 to $35.00 in a report on Friday, June 9th. Finally, Evercore ISI lowered Patheon NV to an “outperform” rating and set a $35.00 price target on the stock. in a report on Monday, May 15th. Eight equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $32.88.
Patheon NV Company Profile
Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company’s segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products.
Want to see what other hedge funds are holding PTHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Patheon NV (NASDAQ:PTHN).
Receive News & Ratings for Patheon NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patheon NV and related companies with MarketBeat.com's FREE daily email newsletter.